Spiro Rombotis
2013
In 2013, Spiro Rombotis earned a total compensation of $1.1M as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 71% increase compared to previous year.
Compensation breakdown
| Bonus | $198,314 |
|---|---|
| Option Awards | $387,241 |
| Salary | $515,100 |
| Other | $28,888 |
| Total | $1,129,543 |
Rombotis received $515.1K in salary, accounting for 46% of the total pay in 2013.
Rombotis also received $198.3K in bonus, $387.2K in option awards and $28.9K in other compensation.
Rankings
In 2013, Spiro Rombotis' compensation ranked 6,075th out of 12,286 executives tracked by ExecPay. In other words, Rombotis earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,075 out of 12,286 | 51st |
Division Manufacturing | 2,116 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 624 out of 1,466 | 57th |
Industry group Drugs | 448 out of 1,160 | 61st |
Industry Pharmaceutical Preparations | 359 out of 890 | 60th |
Source: SEC filing on April 7, 2015.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2013.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020